SGHT
Sight Sciences IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$215.98M
P/E Ratio
—
EPS
$-0.74
Beta
2.49
52W High
$9.24
52W Low
$2.74
50-Day MA
$4.18
200-Day MA
$5.11
Dividend Yield
—
Profit Margin
-49.70%
Forward P/E
—
PEG Ratio
—
About Sight Sciences Inc
Sight Sciences Inc. (SGHT) is a leading medical technology innovator dedicated to revolutionizing the management of eye diseases, particularly glaucoma, through both surgical and non-surgical solutions. The company boasts a diverse array of advanced products and a solid intellectual property portfolio, strategically positioning it to leverage the growing demand for minimally invasive ophthalmic therapies. As Sight Sciences continues to enhance its distribution capabilities and push the boundaries of eye care technology, it represents a compelling investment opportunity for institutional investors seeking exposure in the evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | $77.36M |
| Gross Profit (TTM) | $66.67M |
| EBITDA | $-33.81M |
| Operating Margin | -18.00% |
| Return on Equity | -50.70% |
| Return on Assets | -16.60% |
| Revenue/Share (TTM) | $1.48 |
| Book Value | $1.20 |
| Price-to-Book | 3.38 |
| Price-to-Sales (TTM) | 2.79 |
| EV/Revenue | 2.13 |
| EV/EBITDA | -4.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.90% |
| Shares Outstanding | $54.40M |
| Float | $35.29M |
| % Insiders | 20.03% |
| % Institutions | 48.45% |
Historical Volatility
HV 10-Day
72.36%
HV 20-Day
60.15%
HV 30-Day
60.80%
HV 60-Day
90.64%
HV Rank
29.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.34 target)
1
Strong Buy3
Buy2
HoldData last updated: 4/30/2026